Neurogenetics

, Volume 6, Issue 1, pp 55–56

Epsilon-sarcoglycan is not involved in sporadic Gilles de la Tourette syndrome

Authors

  • Friedrich Asmus
    • Department of Neurodegenerative DiseasesHertie Institute for Clinical Brain Research, Eberhard-Karls University
  • Sarah Schoenian
    • Department of NeurologyPhilipps University
  • Peter Lichtner
    • Institute of Human GeneticsGSF National Research Center
  • Marita Munz
    • Department of Neurodegenerative DiseasesHertie Institute for Clinical Brain Research, Eberhard-Karls University
  • Petra Mayer
    • Department of Neurodegenerative DiseasesHertie Institute for Clinical Brain Research, Eberhard-Karls University
  • Bertram Muller-Myhsok
    • Computational Genetics GroupMax-Planck-Institute for Psychiatry
  • Alexander Zimprich
    • Department of Neurodegenerative DiseasesHertie Institute for Clinical Brain Research, Eberhard-Karls University
    • Department of NeurologyUniversity Hospital
  • Helmut Remschmidt
    • Department of Child and Adolescent PsychiatryPhilipps University
  • Johannes Hebebrand
    • Department of Child and Adolescent PsychiatryRheinische Kliniken, University of Duisburg-Essen
  • Oliver Bandmann
    • Department of NeurologyPhilipps University
    • Academic Neurology UnitE Floor Medical School, University of Sheffield
    • Department of Neurodegenerative DiseasesHertie Institute for Clinical Brain Research, Eberhard-Karls University
Letter to the Editors

DOI: 10.1007/s10048-004-0206-z

Cite this article as:
Asmus, F., Schoenian, S., Lichtner, P. et al. Neurogenetics (2005) 6: 55. doi:10.1007/s10048-004-0206-z

Keywords

DYT-11 Epsilon-sarcoglycan Myoclonus-dystonia SGCE Tourette syndrome

Copyright information

© Springer-Verlag 2004